Incivek will not be available for patients after Oct. 14. While the drug will no longer be in the hepatitis C treatment market, the company has not indicated when it would stop making the drug, according to the report.
More articles on Sovaldi:
Despite price, Sovaldi still treatment of choice for Hep C
Sovaldi generates $3.48B in Q2 sales
60% of Americans Are Worried They Won’t Be Able to Afford Specialty Drugs
Register to Attend Webinar
Presenters:
James Germano, MD, Joint Reconstruction Specialist|Tim Tzimas, Innovative Sterilization Technologies
Next Up in Supply Chain
-
Medical device makers have faced several cyberattacks in 2026, disrupting manufacturing, shipping and order processing for hospitals nationwide. Here’s where…
-
As hospitals redefine the role of supply chain leaders to focus on enterprise strategy, digital transformation and resilience, health systems…
-
Ville Platte, La.-based Mercy Regional Medical Center has signed a prime vendor agreement with Medline for medical-surgical products and distribution…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
